US2016340298A1PendingUtilityA1

Novel compounds

Assignee: AVANTI POLAR LIPIDS INCPriority: Mar 14, 2013Filed: Aug 1, 2016Published: Nov 24, 2016
Est. expiryMar 14, 2033(~6.6 yrs left)· nominal 20-yr term from priority
C12P 13/02Y02P20/582C07C 229/22C07C 271/22A61P 3/06
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are compounds of the general formula I and II (as further defined herein) are useful in the production of inhibitors of sphingolipid synthesis the production of sphingolipids. Suitable sphingolipids, include, but not limited to, sphingosine and compounds incorporating sphingosine or that may use sphingosine as an intermediate or a starting material in their synthesis (including, but not limited to, sphingosine-1-P, ceramide, gangliosides and sphigomyelin). In one contemplated use, compounds of the general formula I and II are useful in the production of sphingosine. In another contemplated use, compounds of the general formula I and II are useful in the production of a sphingofugin. Methods of manufacturing each of the above compounds are also provided.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A compound of the general formula I: 
       
         
           
           
               
               
           
         
         wherein: 
         A is a ketone (═O) or A is R 5  and R 6 ; 
         ---- represents an optional double bond; 
         R 1  is a substituted or unsubstituted alkyl group or, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, or (CH 2 ) n —R 8 ; 
         R 2  is H, substituted or unsubstituted alkyl group or, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group benzyl, or (CH 2 ) p —R 9 ; 
         R 3  is a protecting group; 
         R 4  is H, a substituted or unsubstituted alkyl, a substituted or unsubstituted aralalkyl, a substituted or unsubstituted heterocycloalkyl or a side chain group from any one of the naturally or non-naturally occurring amino acids 
         R 5  is H or a substituted or unsubstituted alkyl, alkenyl or alkynyl group; 
         R 6  is OH or OR 7 ; 
         R 7  is a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl, or a substituted or unsubstituted alkynyl group; 
         R 8  and R 9  are each independently selected from a substituted or unsubstituted aryl, a substituted or unsubstituted aralkyl a substituted or unsubstituted heterocycle or a substituted or unsubstituted heterocycloalkyl; and 
         n and p are each independently selected from 0-10. 
       
     
     
         2 . The compound of  claim 1 , wherein R 3  is a silyl ether, an alkyl ether, an alkoxymethyl ether, a tetrahydropyranyl ether, a methylthiomethyl ethers, an esters or a carbonate. 
     
     
         3 . The compound of  claim 1 , wherein R 3  is OR 10 , wherein R 10  is a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted aryl, a substituted or unsubstituted aralkyl a substituted or unsubstituted heterocycle or a substituted or unsubstituted heterocycloalkyl. 
     
     
         4 . The compound of  claim 1 , wherein R 3  is OR 10 , wherein R 10  is a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl group, or a substituted or unsubstituted alkynyl group. 
     
     
         5 . The compound of  claim 1 , wherein R 3  is an O—CH 3  group or a benzyl group. 
     
     
         6 . The compound of  claim 1 , wherein R 4  is selected from the group consisting of: H, —CH 2 (CH 2 ) m (CH 3 )(CH 3 ), —CH(CH 3 )(CH2) m CH3, —(CH 2 ) m C(═O)(NH 2 ), —(CH 2 ) m COOH, —(CH 2 ) m SCH 3 , —(CH 2 ) m OH, —CH(OH)(CH 2 ) m CH 3 , —(CH 2 ) m SH, CH 2 (CH 2 ) m NH 2 , and —CH 2 (CH 2 ) m NHC(NH 2 )(NH 2 ), wherein m is an integer selected from 1-4 for each occurrence. 
     
     
         7 . The compound of  claim 1 , wherein R 4  is selected from the group consisting of: H, —CH 3 , —CH(CH 3 )(CH 3 ), —CH 2 CH 2 (CH 3 )(CH 3 ), —CH(CH 3 )CH 2 CH 3 , —CH 2 C(═O)(NH 2 ), —CH2CH 2 C(═O)(NH 2 ), —CH 2 COOH, —CH 2 CH 2 COOH, —CH 2 CH 2 SCH 3 , —CH 2 OH, —CH(OH)CH 3 , —CH 2 SH, —CH 2 (CH 2 ) 3 NH 2 , —CH 2 (CH 2 ) 2 NHC(NH 2 )(NH 2 ), 
       
         
           
           
               
               
           
         
       
     
     
         8 . The compound of  claim 1 , wherein R 4  is H, —(CH 2 ) m OH, —CH(OH)(CH 2 ) m CH3, —CH 2 OH or —CH(OH)CH 3 , wherein m is an integer selected from 1-4 for each occurrence. 
     
     
         9 . The compound of  claim 9 , wherein R 1  contains from 1 to 6 substitutions. 
     
     
         10 . The compound of  claim 10 , wherein the substituents on R 1  are independently selected from —OH, —NH 2 , —N 3  or ═O 
     
     
         11 . The compound of  claim 1 , wherein R 1  contains from 1-6 double and/or triple bonds. 
     
     
         12 . The compound of  claim 1 , wherein ---- is present. 
     
     
         13 . The compound of  claim 1 , wherein A is a ketone group, ---- is present, R 1  is an unsubstituted or substituted C 6 -C 14  alkyl, alkenyl or alkynyl group, R 2  is CH 3  or benzyl; R 3  is O—CH 3  and R 4  is H or CH 2 —OH. 
     
     
         14 . The compound of  claim 1 , wherein A is a ketone group, ---- is absent, R 1  is an unsubstituted or substituted C 6 -C 14  alkyl, alkenyl or alkynyl group, R 2  is CH 3  or benzyl, R 3  is O—CH 3  and R 4  is H or CH 2 —OH. 
     
     
         15 . The compound of  claim 1 , wherein A is R 5  and R 6 , where R 5  is H and R 6  is OH, ---- is present, R 1  is an unsubstituted or substituted C 6 -C 14  alkyl, alkenyl or alkynyl group, R 2  is CH 3  or benzyl; R 3  is O—CH 3  and R 4  is H or CH 2 —OH. 
     
     
         16 . The compound of  claim 1 , wherein A is R 5  and R 6 , where R 5  is H and R 6  is OH, ---- is absent, R 1  is an unsubstituted or substituted C 6 -C 14  alkyl, alkenyl or alkynyl group, R 2  is CH 3  or benzyl, R 3  is O—CH 3  and R 4  is H or CH 2 —OH. 
     
     
         17 . The compound of  claim 1 , wherein the compound has the a structure selected from the group consisting of: 
       
         
           
           
               
               
           
         
       
     
     
         18 . The compound of  claim 1 , wherein the compound is used in the synthesis of a sphingolipid. 
     
     
         19 . The compound of  claim 1 , wherein the compound is used in the synthesis of a sphingosine. 
     
     
         20 . A compound of the general formula II: 
       
         
           
           
               
               
           
         
         wherein: 
         A is a ketone (═O) or A is R 5  and R 6 ; 
         ---- represents an optional double bond; 
         R 1  is a substituted or unsubstituted alkyl group or, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, or (CH 2 ) n —R 8 ; 
         R 3  is a protecting group; 
         R 4  is H, a substituted or unsubstituted alkyl, a substituted or unsubstituted aralalkyl, a substituted or unsubstituted heterocycloalkyl or a side chain group from any one of the naturally or non-naturally occurring amino acids; 
         R 5  is H or a substituted or unsubstituted alkyl, alkenyl or alkynyl group; 
         R 6  is a OH or OR 7 ; 
         R 7  is a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl, or a substituted or unsubstituted alkynyl group; 
         R 8  is a substituted or unsubstituted aryl, a substituted or unsubstituted aralkyl a substituted or unsubstituted heterocycle or a substituted or unsubstituted heterocycloalkyl; and 
         n is an integer from 0-10.

Join the waitlist — get patent alerts

Track US2016340298A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.